Chemoinformaics analysis of PROCYANIDIN-B-4
Molecular Weight | 578.526 | nRot | 3 |
Heavy Atom Molecular Weight | 552.318 | nRig | 34 |
Exact Molecular Weight | 578.142 | nRing | 6 |
Solubility: LogS | -3.968 | nHRing | 2 |
Solubility: LogP | 1.853 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 4 |
nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 24 |
No. of Oxygen atom | 12 | No. of Arom Bond | 24 |
nHA | 12 | APOL | 77.0606 |
nHD | 10 | BPOL | 29.5554 |
QED | 0.159 |
Synth | 4.519 |
Natural Product Likeliness | 1.929 |
NR-PPAR-gamma | 0.91 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.041 |
Pgp-sub | 0 |
HIA | 0.964 |
CACO-2 | -6.774 |
MDCK | 0.0000043 |
BBB | 0.006 |
PPB | 0.887066 |
VDSS | 0.436 |
FU | 0.0787454 |
CYP1A2-inh | 0.016 |
CYP1A2-sub | 0.134 |
CYP2c19-inh | 0.024 |
CYP2c19-sub | 0.045 |
CYP2c9-inh | 0.542 |
CYP2c9-sub | 0.903 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.232 |
CYP3a4-inh | 0.066 |
CYP3a4-sub | 0.446 |
CL | 13.419 |
T12 | 0.612 |
hERG | 0.023 |
Ames | 0.27 |
ROA | 0.603 |
SkinSen | 0.954 |
Carcinogencity | 0.03 |
EI | 0.902 |
Respiratory | 0.021 |
NR-Aromatase | 0.759 |
Antiviral | Yes |
Prediction | 0.798061 |